skip to primary navigationskip to content
 

Drug Discovery Roadshow - identify, validate, invest

Find out how to refine your research idea into a tangible drug discovery project and meet some of the major funders of translational and applied biomedical research in the UK.
When Dec 05, 2016
from 10:00 AM to 02:00 PM
Where CRUK Cambridge Institute, Cambridge Biomedical Campus CB2 0RE
Add event to calendar vCal
iCal

The format of the event will be presentations in the morning, followed by the opportunity to talk to representatives from the major funders and experts in drug development and commercialisation. 

The aims of the roadshow are to:

  • Support you to refine your research idea into a tangible drug discovery project in your disease area of interest
  • Provide access to experienced drug discovery scientists to discuss your projects of interest
  • Offer insight from big pharma on what ‘validation’ means 
  • Give you opportunity to talk to some of the major funders of translational and applied biomedical research in the UK

The roadshow is a collaboration between Charles River Laboratories, the Milner Therapeutics Institute, the Office of Translational Research and the Bioscience Impact Team.

Register here by 23 November. If you have any questions, please contact or .

OPdA Tweets

Upcoming events

CEGX: The spinout that’s measuring the epigenome to improve human health

Sep 12, 2017

Pfizer Lecture Theatre, Department of Chemistry, Lensfield Road

Pitching Training Event

Sep 15, 2017

Seminar Room B, 17 Mill Lane

Upcoming events

RSS Feed Latest news

Grants available through the Returning Carers Scheme - apply by 29 September

Aug 16, 2017

The Returning Carers Scheme provides funds to support career development following a career break or a period of leave for caring responsibilities.

Opportunity to apply for up to £30,000 funding from the EPSRC: apply by 16 August

Aug 08, 2017

Postdocs are invited to apply via the OPdA for funding for activities which fall under the remit of the EPSRC and the Global Challenges Research Fund.

View all news